BIIB
Biogen Inc
Price:  
230.57 
USD
Volume:  
985,031.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Biogen WACC - Weighted Average Cost of Capital

The WACC of Biogen Inc (BIIB) is 8.4%.

The Cost of Equity of Biogen Inc (BIIB) is 9.30%.
The Cost of Debt of Biogen Inc (BIIB) is 4.55%.

Range Selected
Cost of equity 7.90% - 10.70% 9.30%
Tax rate 13.90% - 16.80% 15.35%
Cost of debt 4.00% - 5.10% 4.55%
WACC 7.1% - 9.6% 8.4%
WACC

Biogen WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.87 1.05
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.90% 10.70%
Tax rate 13.90% 16.80%
Debt/Equity ratio 0.21 0.21
Cost of debt 4.00% 5.10%
After-tax WACC 7.1% 9.6%
Selected WACC 8.4%